İrritabl Bağırsak Sendromlu Hastalarda Laktoz İntoleransı ve Osteoporoz Gelişimi

Yıl 2022, , 253 - 260, 26.12.2022

Melis Aycan , Aylin Açıkgöz Pınar

https://doi.org/10.46413/boneyusbad.1184664

Öz

İrritabl bağırsak sendromu (IBS), gastrointestinal sistem hastalıkları arasında en sık görülen kronik fonksiyonel bozukluklardan biridir. Dünya genelinde prevalansı yüksek olan IBS, hastaların yaşam kalitesini olumsuz yönde etkilemektedir. IBS'nin gelişiminde etkili olan mekanizmalar tam olarak anlaşılamamıştır. Ancak mekanizmasının multifaktöriyel olduğu düşünülmektedir. IBS, karın ağrısı, ishal, kabızlık, gaz ve hazımsızlık gibi belirli semptomlarla karakterizedir. Bununla birlikte, bu semptomlar IBS'ye özgü değildir ve sıklıkla laktoz intoleransı (LI) semptomları ile karşılaşılabilmektedir. Öte yandan İBS hastalarında aynı anda LI görülme olasılığı oldukça yüksektir. IBS hastaları, semptomlarını tetikledikleri düşüncesiyle laktoz içeren gıdaları özellikle süt ve süt ürünlerini kısıtlamakta ve bunun sonucunda kalsiyum eksikliği oluşabilmektedir. Bu hastaların uzun süre yetersiz kalsiyum alması sonucunda osteoporoz ve osteoporotik kırık riski önemli bir sorun haline gelmektedir. Tüm bu faktörler doğrultusunda bu derleme, İBS hastalarında LI varlığına bağlı olarak gelişebilecek osteoporozu incelemeyi ve beslenme önerilerinde bulunmayı amaçlamaktadır.

Anahtar Kelimeler

Beslenme tedavisi, İrratablo barsak sendromu, Laktoz İntoleransı, Osteoporoz

Lactose Intolerance and Osteoporosis Development in Irritable Bowel Syndrome Patients

Öz

Irritable bowel syndrome (IBS) is one of the most common chronic functional disorders among gastrointestinal system diseases. IBS, which has a high prevalence worldwide, negatively affects the quality of life of patients. The mechanisms that are effective in the development of IBS has not clearly been defined. However, its mechanism is thought to be multifactorial. IBS is characterized by certain symptoms, such as abdominal pain, diarrhea, constipation, flatulence, and indigestion. Nevertheless, these symptoms aren’t specific to IBS and can often be confused with lactose intolerance (LI) symptoms. On the other hand, the probability of having LI at the same time is quite high in IBS patients. IBS patients restrict lactose-containing foods, especially milk and dairy products, due to the thought that they trigger their symptoms, and thus calcium deficiency may occur as a result. Due to insufficient calcium intake for a long time, the risk of osteoporosis and osteoporotic fractures becomes an important problem. In line with all these factors, this review aims to examine osteoporosis that may develop due to the presence of LI in IBS patients and to make nutritional recommendations.

Anahtar Kelimeler

Nutritional treatment, Irritable bowel syndrome, Lactose intolerence, Osteopororsis

Kaynakça

• Algera, J., Colomier, E., Simrén, M. (2019). The dietary management of patients with irritable bowel syndrome: A narrative review of the existing and emerging evidence. Nutrients, 11(9). doi:10.3390/nu11092162
• Ali, T., Lam, D., Bronze, M. S., Humphrey, M. B. (2009). Osteoporosis in inflammatory bowel disease. American Journal of Medicine, 122(7), 599-604. doi:10.1016/j.amjmed.2009.01.022
• Alkan, B. M., Fidan, F., Tosun, A., Ardıçoğlu, Ö. (2011). Fiziksel Tıp ve rehabilitasyon polikliniğimize başvuran hastalarda osteoporoz insidansı. Turkish Journal of Osteoporosis, 17(1), 0-0.
• Almazar, A. E., Chang, J. Y., Larson, J. J., Atkinson, E. J., Locke, G. R., Talley, . . . N. J., Saito, Y. A. (2019). Comparison of lactase variant MCM6 -13910 C>T testing and self-report of dairy sensitivity in patients with irritable bowel syndrome. Journal of Clinical Gastroenterology, 53(6), e227-e231. doi:10.1097/mcg.0000000000001065
• Bellini, M., Tonarelli, S., Mumolo, M. G., Bronzini, F., Pancetti, A., Bertani, L., . . . Rossi, A. (2020). Low fermentable oligo- di- and mono-saccharides and polyols (FODMAPs) or gluten free diet: What is best for irritable bowel syndrome? Nutrients, 12(11). doi:10.3390/nu12113368
• Bianchi, M. L. (2010). Inflammatory bowel diseases, celiac disease, and bone. Archives of Biochemistry and Biophysics, 503(1), 54-65. doi:10.1016/j.abb.2010.06.026
• Black, C. J., Ford, A. C. (2020). Rational investigations in irritable bowel syndrome. Frontline Gastroenterology, 11(2), 140-147. doi:10.1136/flgastro-2019-101211
• Campbell, A. K., Matthews, S. B., Vassel, N., Cox, C. D., Naseem, R., Chaichi, J., . . . Wann, K. T. (2010). Bacterial metabolic 'toxins': a new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology, 278(3), 268-276. doi:10.1016/j.tox.2010.09.001
• Cancarevic, I., Rehman, M., Iskander, B., Lalani, S., Malik, B. H. (2020). Is there a correlation between irritable bowel syndrome and lactose intolerance? Cureus, 12(1), e6710. doi:10.7759/cureus.6710
• Casellas, F., Burgos, R., Marcos, A., Santos, J., Ciriza de Los Ríos, C., García Manzanares, Á., . . . Vázquez Alférez, M. D. C. (2018). Consensus document on exclusion diets in irritable bowel syndrome (IBS). Revista Espanola de Enfermadades Digestivas, 110(12), 806-824. doi:10.17235/reed.2018.5941/2018
• Celebi, S., Acik, Y., Deveci, S. E., Bahcecioglu, I. H., Ayar, A., Demir, A., . . . Durukan, P. (2004). Epidemiological features of irritable bowel syndrome in a Turkish urban society. Journal of Gastroenterology and Hepatology, 19(7), 738-743. doi:10.1111/j.1440-1746.2004.03367.x
• Chey, W. D., Keefer, L., Whelan, K., Gibson, P. R. (2021). Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome. Gastroenterology, 160(1), 47-62. doi:10.1053/j.gastro.2020.06.099
• Chey, W. D., Kurlander, J., Eswaran, S. (2015). Irritable bowel syndrome: A clinical review. Jama, 313(9), 949-958. doi:10.1001/jama.2015.0954
• Compston, J. E. (2013). Bone: Risk of osteoporotic fractures in irritable bowel syndrome. Nature Reviews Endocrinology, 9(1), 8-9. doi:10.1038/nrendo.2012.216
• Cozma-Petruţ, A., Loghin, F., Miere, D., Dumitraşcu, D. L. (2017). Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World Journal of Gastroenterology: WJG, 23(21), 3771-3783. doi:10.3748/wjg.v23.i21.3771
• Dabak, M. R., Küçük, T. A., Tüzün, S., Çetin, H., Ahıshalı, E., Dolapçıoğlu, C. (2019). İrritabl barsak sendromu ve laktoz İntoleransı İlişkisi. Namık Kemal Tıp Dergisi, 7(3), 217-221.
• Deng, Y., Misselwitz, B., Dai, N., Fox, M. (2015). Lactose intolerance in adults: Biological mechanism and dietary management. Nutrients, 7(9), 8020-8035. doi:10.3390/nu7095380
• Facioni, M. S., Raspini, B., Pivari, F., Dogliotti, E., Cena, H. (2020). Nutritional management of lactose intolerance: the importance of diet and food labelling. Journal of Translational Medicine, 18(1), 260. doi:10.1186/s12967-020-02429-2
• Hodges, J. K., Cao, S., Cladis, D. P., Weaver, C. M. (2019). Lactose intolerance and bone health: The challenge of ensuring adequate calcium intake. Nutrients, 11(4). doi:10.3390/nu11040718
• Jackson, K. A., Savaiano, D. A. (2001). Lactose maldigestion, calcium intake and osteoporosis in African-, Asian-, and Hispanic-Americans. Journal of the American College of Nutrition, 20(2 Suppl), 198s-207s. doi:10.1080/07315724.2001.10719032
• Jansson-Knodell, C. L., Krajicek, E. J., Savaiano, D. A., Shin, A. S. (2020). Lactose intolerance: A concise review to skim the surface. Mayo Clinic Proceedings, 95(7), 1499-1505. doi:10.1016/j.mayocp.2020.04.036
• Kumar, S., Ranjan, P., Mittal, B., Singh, R., Ghoshal, U. C. (2012). Lactase persistence/non-persistence genetic variants in irritable bowel syndrome in an endemic area for lactose malabsorption. Journal of Gastroenterology and Hepatology, 27(12), 1825-1830. doi:10.1111/j.1440-1746.2012.07259.x
• Le Morvan de Sequeira, C., Kaeber, M., Cekin, S. E., Enck, P., Mack, I. (2021). The effect of probiotics on quality of life, depression and anxiety in patients with irritable bowel syndrome: A systematic review and meta- analysis. Journal of Clinical Medicine, 10(16). doi:10.3390/jcm10163497
• Lee, H. J., Kim, H. J., Kang, E. H., Jung, K. W., Myung, S. J., Min, Y. W., . . . Park, K. S. (2019). Self-reported food intolerance in Korean patients with irritable bowel syndrome. Journal of Neurogastroenterololgy and Motility, 25(2), 222-232. doi:10.5056/jnm18125
• Lee, H. S., Chen, C. Y., Huang, W. T., Chang, L. J., Chen, S. C., Yang, H. Y. (2018). Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: A nationwide population-based cohort study. Archives of Osteoporosis, 13(1), 80. doi:10.1007/s11657-018-0496-7
• Lomer, M. C., Parkes, G. C., Sanderson, J. D. (2008). Review article: Lactose intolerance in clinical practice-myths and realities. Alimentary Pharmacology & Therapeutics, 27(2), 93-103. doi:10.1111/j.1365-2036.2007.03557.x
• Lopes, S. S., Miszputen, S. J., Sachs, A., Lima, M. M., Ambrogini, O., Jr. (2019). Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arquivos de Gastroenterologia, 56(1), 3-9. doi:10.1590/s0004-2803.201900000-12
• Lovell, R. M., Ford, A. C. (2012). Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clinical Gastroenterology and Hepatology, 10(7), 712-721.e714. doi:10.1016/j.cgh.2012.02.029
• Mądry, E., Fidler, E. (2010). Lactose intolerance–current state of knowledge. Acta Scientiarum Polonorum Technologia Alimentaria, 9(3), 343-350.
• Malik, T. F., Panuganti, K. K. (2021). Lactose intolerance. In StatPearls. Treasure Island (FL): StatPearls Publishing.
• McKenzie, Y. A., Alder, A., Anderson, W., Wills, A., Goddard, L., Gulia, P., . . . Lomer, M. C. (2012). British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. Journal of Human Nutrition and Dietetics, 25(3), 260-274. doi:10.1111/j.1365-277X.2012.01242.x
• Misselwitz, B., Butter, M., Verbeke, K., Fox, M. R. (2019). Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut, 68(11), 2080-2091. doi:10.1136/gutjnl-2019-318404
• Monsbakken, K. W., Vandvik, P. O., Farup, P. G. (2006). Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. European Journal of Clinical Nutrition, 60(5), 667- 672. doi:10.1038/sj.ejcn.1602367
• Özden, A., Köksal, A. Ş., Dilek, O., Çiçek, B., Yılmaz, U., Dağlı, Ü., . . . Özler, J. (2006). Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı. Akademik Gastroenteroloji Dergisi, 5(1):4-15(1), 4-15.
• Quigley, E. M., Fried, M., Gwee, K. A., Khalif, I., Hungin, A. P., Lindberg, G., . . . LeMair, A. (2016). World Gastroenterology Organisation Global Guidelines irritable bowel syndrome: A global perspective update September 2015. Journal of Clinical Gastroenterology, 50(9), 704-713. doi:10.1097/mcg.0000000000000653
• Ratajczak, A. E., Rychter, A. M., Zawada, A., Dobrowolska, A., Krela-Kaźmierczak, I. (2021). Lactose intolerance in patients with inflammatory bowel diseases and dietary management in prevention of osteoporosis. Nutrition, 82, 111043. doi:10.1016/j.nut.2020.111043
• Savaiano, D. (2011). Lactose intolerance: An unnecessary risk for low bone density. Milk and Milk Products in Human Nutrition, 67, 161-171. doi:10.1159/000325582
• Shah-Khan, S. M., Cumberledge, J., Shah-Khan, S. M., Gannon, K., Kupec, J. T. (2019). Improving bone mineral density screening in patients with inflammatory bowel disease: a quality improvement report. BMJ Open Quality, 8(3), e000624. doi:10.1136/bmjoq-2019-000624
• Silva, C. J., Leite, I. D. S., Rodrigues, J. W., Almeida, S. P., Nóbrega, B. P., Sampaio Filho, J. D. R. (2019). Analysis of lactose intolerance in students with suggestive symptoms of irritable bowel syndrome. Arquivos de Gastroenterologia, 56(3), 304-311. doi:10.1590/s0004-2803.201900000-57
• Solar, I., Santos, L. A. O., Yamashita, L. M., Barret, J. S., Nagasako, C. K., Montes, C. G., . . . Vasques, A. C. J. (2019). Irritable bowel syndrome: associations between FODMAPS intake, problematic foods, adiposity, and gastrointestinal symptoms. European Journal of Clinical Nutrition, 73(4), 637-641. doi:10.1038/s41430-018- 0331-7
• Staudacher, H. (2015). Probiotics for lactose intolerance and irritable bowel syndrome. British Journal of Community Nursing, S12, s14. doi:10.12968/bjcn.2015.20.Sup6a.S12
• Stobaugh, D. J., Deepak, P., Ehrenpreis, E. D. (2013). Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporosis International, 24(4), 1169-1175. doi:10.1007/s00198-012-2141-4
• Torres, M. J., Sabate, J. M., Bouchoucha, M., Buscail, C., Hercberg, S., Julia, C. (2018). Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study. Therapeutic Advances in Gastroenterology, 11, 1756283x17746625. doi:10.1177/1756283x17746625
• Varjú, P., Gede, N., Szakács, Z., Hegyi, P., Cazacu, I. M., Pécsi, D., . . . Czimmer, J. (2019). Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: A meta-analysis. Neurogastroenterology & Motility, 31(5), e13527. doi:10.1111/nmo.13527
• Vernia, P., Loizos, P., Di Giuseppantonio, I., Amore, B., Chiappini, A., Cannizzaro, S. (2014). Dietary calcium intake in patients with inflammatory bowel disease. Journal of Crohn's and Colitis, 8(4), 312-317. doi:10.1016/j.crohns.2013.09.008
• Wongtrakul, W., Charoenngam, N., Ungprasert, P. (2020). The association between irritable bowel syndrome and osteoporosis: A systematic review and meta-analysis. Osteoporosis International, 31(6), 1049-1057. doi:10.1007/s00198-020-05318-y
• Xiong, L., Wang, Y., Gong, X., Chen, M. (2017). Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: Data from a tertiary center in southern China. Journal of Health, Population and Nutrition, 36(1), 38. doi:10.1186/s41043-017-0113-1
• Yang, J. F., Fox, M., Chu, H., Zheng, X., Long, Y. Q., Pohl, D., . . . Dai, N. (2015). Four-sample lactose hydrogen breath test for diagnosis of lactose malabsorption in irritable bowel syndrome patients with diarrhea. World Journal of Gastroenterology: WJG, 21(24), 7563-7570. doi:10.3748/wjg.v21.i24.7563
• Yen, C. M., Muo, C. H., Lin, M. C., Chang, S. N., Chang, Y. J., Kao, C. H. (2014). A nationwide population cohort study: Irritable bowel syndrome is a risk factor of osteoporosis. European Journal of Internal Medicine, 25(1), 87-91. doi:10.1016/j.ejim.2013.10.009
• Zamani, M., Zamani, V., Heidari, B., Parsian, H., Esmaeilnejad-Ganji, S. M. (2018). Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: A systematic review and meta-analysis. Archives of Osteoporosis, 13(1), 129. doi:10.1007/s11657-018-0540-7
• Zhu, Y., Zheng, X., Cong, Y., Chu, H., Fried, M., Dai, N., . . . Fox, M. (2013). Bloating and distention in irritable bowel syndrome: The role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. American Journal of Gastroenterology, 108(9), 1516-1525. doi:10.1038/ajg.2013.198